TipRanks
Pharmadrug (DE:G11)
FRANKFURT:G11
Germany Market
G11
Pharmadrug
RESEARCH TOOLSreports

Pharmadrug (G11) Income Statement

0 Followers

Pharmadrug Income Statement

Last quarter (Q2 2026), Pharmadrug's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q2, Pharmadrug's net income was C$-243.74K. See Pharmadrug’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Mar 23Mar 22
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 7.01K
Gross Profit
C$ -50.24KC$ -50.24KC$ -26.22KC$ -2.26KC$ -2.15K
Operating Expenses
C$ 175.69KC$ 618.41KC$ 1.33MC$ 1.49MC$ 2.79M
Depreciation and Amortization
C$ 50.24KC$ 50.24KC$ 26.22KC$ 21.03KC$ 16.02K
EBITDA
C$ -71.98KC$ -549.04KC$ -1.33MC$ -2.34MC$ -4.21M
Operating Income
C$ -225.93KC$ -668.66KC$ -1.33MC$ -2.43MC$ -2.80M
Other Income/Expenses
C$ -206.57KC$ -204.50KC$ -12.94MC$ -824.00KC$ -1.49M
Pretax Income
C$ -432.50KC$ -873.15KC$ -14.27MC$ -3.25MC$ -4.28M
Net Income
C$ -383.38KC$ -793.27KC$ -13.20MC$ -8.88MC$ -5.87M
Per Share Metrics
Basic EPS
C$ >-0.01C$ >-0.01C$ -0.23C$ -0.13C$ -0.12
Diluted EPS
C$ >-0.01C$ >-0.01C$ -0.23C$ -0.13C$ -0.12
Weighted Average Shares Outstanding
 108.12M 103.93M 56.49M 50.09M 47.31M
Weighted Average Shares Outstanding (Diluted)
 108.12M 103.93M 56.49M 50.09M 47.31M
Currency in CAD

Pharmadrug Earnings and Revenue History